Kropivsek, Klara http://orcid.org/0000-0003-1866-4094
Kachel, Paul
Goetze, Sandra http://orcid.org/0000-0001-6880-8020
Wegmann, Rebekka http://orcid.org/0000-0001-9616-3303
Festl, Yasmin
Severin, Yannik
Hale, Benjamin D.
Mena, Julien
van Drogen, Audrey
Dietliker, Nadja
Tchinda, Joƫlle
Wollscheid, Bernd
Manz, Markus G. http://orcid.org/0000-0002-4676-7931
Snijder, Berend http://orcid.org/0000-0003-3386-6583
Article History
Received: 27 April 2022
Accepted: 17 March 2023
First Online: 20 April 2023
Competing interests
: B.S. was a scientific co-founder of Allcyte, which has been acquired by Exscientia. B.S. is a shareholder of Exscientia and a co-inventor on US patent application 15/514,045 relevant to the study. B.S. declares research funding from Roche and speaker fees from Novartis, GSK and AbbVie. All other authors declare no competing interests.